United States · 
How much has Neurona Therapeutics raised?
Neurona Therapeutics has raised $102M across 1 round since 2025.
United States · Funded startup
Who invested in Neurona Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Neurona Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$102Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $102MApr 2025
- Investors
- 0
The rounds
- Apr 2025Round$102M
No investor was named in the report.
Reported by Firms' own news pagesSEC filing: $102M sold, first sale Mar 2025
Founders and team
From Neurona Therapeutics's own website: 5 on the team.
- Agape EleftheriadisVice President of Human Resources
- Alexis van LingenVice President of Quality
- James TanakaVice President of Finance and Accounting
- Sheri MadridVice President of Clinical Operations and Development
- James StutzChief Financial Officer and Chief Business Officer
Also claim to have backed them
These 2 firms list Neurona Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Neurona Therapeutics
When did Neurona Therapeutics last raise?
Neurona Therapeutics's most recent round was an Undisclosed round of $102M in Apr 2025.
What was Neurona Therapeutics's biggest round?
Its most recent round, $102M in Apr 2025, is also its largest on record.
What stage is Neurona Therapeutics at?
Neurona Therapeutics's latest named round is an Undisclosed round, in Apr 2025.
Where is Neurona Therapeutics based?
Neurona Therapeutics is based in the United States.
Companies like Neurona Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.